C - Chemistry – Metallurgy – 07 – D
Patent
C - Chemistry, Metallurgy
07
D
C07D 487/04 (2006.01) A61K 31/4985 (2006.01) A61P 35/00 (2006.01)
Patent
CA 2740975
Provided herein are Heteroaryl Compounds having the following structure: R2 N(I) or (II) wherein R1 -R4 are as defined herein, compositions comprising an effective amount of a Heteroaryl Compound and methods for treating or preventing cancer, inflammatory conditions, immunological conditions, neurodegenerative diseases, diabetes, obesity, neurological disorders, age-related diseases, or cardiovascular conditions, comprising administering an effective amount of a Heteroaryl Compound to a patient in need thereof.
Cette invention concerne des composés hétéroaryle présentant la structure suivante : R2 N(I) ou B (II) où R1-R4 sont tels que définis dans le descriptif, des compositions comprenant une dose efficace dun composé hétéroaryle, et des méthodes de traitement ou de prévention du cancer, détats inflammatoires, de troubles immunologiques, de maladies dégénératives, du diabète, de lobésité, de troubles neurologiques, de maladies liées à lâge ou de pathologies cardiovasculaires, consistant à administrer une dose efficace dun composé hétéroaryle à un patient qui en a besoin.
Elsner Jan
Fultz Kimberly
Harris Roy L.
Lee Branden
Madakamutil Loui
Osler Hoskin & Harcourt Llp
Signal Pharmaceuticals Llc
LandOfFree
Mtor kinase inhibitors for oncology indications and diseases... does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Mtor kinase inhibitors for oncology indications and diseases..., we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Mtor kinase inhibitors for oncology indications and diseases... will most certainly appreciate the feedback.
Profile ID: LFCA-PAI-O-1357463